PRI’s regulation database documents financial and corporate policies and regulations which support, encourage or require responsible investment practice. The 2026 update tightens the focus to cover 11 sustainable…
The 2024 Access to Medicine Index analyses 20 of the largest research-based pharmaceutical companies on their efforts to improve access to essential medicines for 81 high-burden diseases across 113 low- and middle-income countries…
Climate Action 100+ is an investor initiative to ensure the world’s largest corporate greenhouse gas emitters take necessary action on climate change. Since its launch in December 2017,…
Private markets action on climate change: a collective commitment to understand and reduce carbon emissions of private markets-backed companies and secure sustainable investment performance.